Will resume COVID-19 vaccine trials after DCGI nod: Serum Institute
Posted by
www.biotecnika.org
Pharma giant AstraZeneca on Saturday said that clinical trials for the
AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the
UK following confirmation by the Medicines Health Regulatory Authority
(MHRA) that the trials were safe.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/will-resume-covid-19-vaccine-trials-after-dcgi-nod-serum-institute/articleshow/78081119.cms
Subscribe to:
Post Comments (Atom)
Post a Comment